GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
GSK's phase 3 trial shows Blenrep combined with BorDex improves overall survival in relapsed multiple myeloma.
Acsh.org12h
Chaos in the Courts: Updates and Insights, and How to Store your Valsartan
Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...
The Healthy on MSN1d
Multiple Over-the-Counter Decongestants May Be Pulled from the Market, Warns the FDA
For those sniffling, sneezing, stuffy head symptoms lurking right around the corner, see whether your preferred medicine will ...
First Alert 4 Investigates: Fix for out-of-stock pharmaceuticals could have ties to St. Louis
First Alert 4 continues its work to uncover the solution for the national drug shortage gripping tens of millions of ...
These 2 former stock market darlings are trying my patience! Time to sell?
Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks. Now they're getting on his nerves. The post These 2 former stock market darlings ...